What Are The Warnings On Fleet Phospho Soda?
In December 2008, the Food and Drug Administration issued a warning against the use of Fleet Phospho Soda, an over-the-counter laxative. In
connection to this, Visicola and OsmoPrep, the prescription versions of the drug were required to use the black box to warn users of associated risks.
Fleet Phospho is routinely given to patients in preparation for colonoscopy procedures. It was supposed to be considered safe and effective. Its
ingredients are monobasic sodium phosphate, mohohydrated and dibasic sodium phosphate heptahydrate.
Consumers who used Phospho Soda Bowel prep suffered various side effects, which included rectal bleeding, constipation, seizures, ulcers and sores
around the rectum, drowsiness, mood changes, loss of appetite and nausea.
Others have also experienced vomiting, irregular heart rate, limited or lacking urination, swelling, weight gain and shortness of breath. The most
severe of side effects is Acute Phosphate Nephropathy, APN, which occurs in connection with the use of oral sodium phosphate, OSP, and begins
with the formation of crystals in the renal tubules.
Lengthen use of Fleet Phospho resulted to severe damage on kidney, most cases required organ transplants. The absence of dialysis and transplants
may lead to death. Osmo Prep has also many life-threatening side effects.
Dr. Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research commented that there are serious adverse effects
associated with the use of oral sodium phosphates whether prescribed or bought over-the-counter.
There are even circumstances in which the APN was diagnosed in patients whom were very unlikely to develop kidney damage. Many of the patients
were dehydrated before their ingestion of OSP products or failed to drink sufficient fluids after its ingestion.
Acute Phosphate Nephropathy often occurs after using OSP products. At most, individuals with pre-existing conditions are most likely to manifest the
malady. Risk factors include people who have